Disease progression in a pre-symptomatically treated patient with juvenile-onset Pompe disease

YIN-HSIU CHIENNI-CHUNG LEEWUH-LIANG HWUFang J.-Y.2020-12-092020-12-0920181351-5101https://www.scopus.com/inward/record.uri?eid=2-s2.0-85052987290&doi=10.1111%2fene.13730&partnerID=40&md5=e3847f61ff1fb3c0f92a4cdb46cccf27https://scholars.lib.ntu.edu.tw/handle/123456789/525091[SDGs]SDG3creatine kinase; creatine kinase blood level; disease exacerbation; enzyme replacement; fatigue; forced vital capacity; glycogen storage disease type 2; human; Letter; muscle biopsy; muscle weakness; myalgia; paraspinal muscle; priority journal; quadriceps femoris muscle; six minute walk test; adult; consensus; disease exacerbation; skeletal muscle; Adult; Consensus; Disease Progression; Enzyme Replacement Therapy; Glycogen Storage Disease Type II; Humans; Muscle, SkeletalDisease progression in a pre-symptomatically treated patient with juvenile-onset Pompe disease – need for an earlier treatment?letter10.1111/ene.13730301920612-s2.0-85052987290